- Home
- FTEK vs SNY Comparison
FTEK vs SNY Comparison
Compare FTEK & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTEK
- SNY
- Stock Information
- Founded
- FTEK 1987
- SNY 1994
- Country
- FTEK United States
- SNY France
- Employees
- FTEK N/A
- SNY N/A
- Industry
- FTEK Pollution Control Equipment
- SNY Biotechnology: Pharmaceutical Preparations
- Sector
- FTEK Industrials
- SNY Health Care
- Exchange
- FTEK Nasdaq
- SNY Nasdaq
- Market Cap
- FTEK N/A
- SNY 123.6B
- IPO Year
- FTEK N/A
- SNY N/A
- Fundamental
- Price
- FTEK $0.97
- SNY $53.63
- Analyst Decision
- FTEK Strong Buy
- SNY Buy
- Analyst Count
- FTEK 1
- SNY 2
- Target Price
- FTEK $4.00
- SNY $62.50
- AVG Volume (30 Days)
- FTEK 42.4K
- SNY 3.4M
- Earning Date
- FTEK 05-06-2025
- SNY 04-24-2025
- Dividend Yield
- FTEK N/A
- SNY 3.00%
- EPS Growth
- FTEK N/A
- SNY 2.94
- EPS
- FTEK N/A
- SNY 5.45
- Revenue
- FTEK $25,133,000.00
- SNY $48,817,552,946.00
- Revenue This Year
- FTEK $22.06
- SNY $5.35
- Revenue Next Year
- FTEK $10.39
- SNY $6.69
- P/E Ratio
- FTEK N/A
- SNY $9.82
- Revenue Growth
- FTEK N/A
- SNY 7.73
- 52 Week Low
- FTEK $0.87
- SNY $45.80
- 52 Week High
- FTEK $1.34
- SNY $60.12
- Technical
- Relative Strength Index (RSI)
- FTEK 46.92
- SNY 50.20
- Support Level
- FTEK $0.96
- SNY $50.46
- Resistance Level
- FTEK $1.01
- SNY $51.64
- Average True Range (ATR)
- FTEK 0.04
- SNY 1.60
- MACD
- FTEK 0.00
- SNY 0.15
- Stochastic Oscillator
- FTEK 54.55
- SNY 65.92
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.